2015 May 07
Safety switches may redeem potent CAR T cancer therapies
Laurie H. Glimcher provides commentary on new data reporting therapies that involve using CAR T cells, white blood cells taken from the body and genetically modified to have the cancer-spotting traits of antibodies. Read more